1. Home
  2. NYAX vs AGIO Comparison

NYAX vs AGIO Comparison

Compare NYAX & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$67.29

Market Cap

2.6B

Sector

N/A

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$40.16

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NYAX
AGIO
Founded
2005
2007
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.3B
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
NYAX
AGIO
Price
$67.29
$40.16
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$49.50
$38.88
AVG Volume (30 Days)
10.9K
1.1M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$43,011,000.00
Revenue This Year
$30.66
$76.75
Revenue Next Year
$21.70
$170.73
P/E Ratio
$89.78
N/A
Revenue Growth
N/A
N/A
52 Week Low
$39.17
$22.24
52 Week High
$76.86
$46.00

Technical Indicators

Market Signals
Indicator
NYAX
AGIO
Relative Strength Index (RSI) 52.41 62.25
Support Level $62.44 $39.31
Resistance Level $68.79 $43.81
Average True Range (ATR) 1.98 1.67
MACD -0.04 -0.35
Stochastic Oscillator 45.81 49.94

Price Performance

Historical Comparison
NYAX
AGIO

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It unifies payments, operations management, and customer engagement tools into a powerful, adaptable platform for modern commerce. It provides solutions that empower businesses to enhance customer experience, accept cashless payments, and manage their operations with a robust Internet of Things (IoT) software platform, helping achieve long-term growth. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: